港股異動 | 江南布衣(3306.HK)漲超7%創歷史新高 市值突破100億港元
格隆匯7月21日丨江南布衣(3306.HK)今日續漲,盤中一度漲超7%至19.3港元,股價創歷史新高,市值突破100億港元,該股今年迄今已累漲超1.2倍。江南布衣15日晚間發盈喜稱,預計截至今年6月30日止年度淨利潤較上年度淨利潤增加超過80%。花旗發研報指,江南布衣發盈喜,較該行及市場預期超出30%,主要由於各品牌收入勝預期及營銷開支較預期少。該行預期,江南布衣復甦步伐理想,公司對品牌及會員制度持續投入,預期6月底止全財年收入將按年升30%,並估計有部分營銷預算將留待下個財年使用,基於業務好過預期及前景向好,將目標價由14港元上調16.8港元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.